1029784

Horizon Pharma Inc - US Operations — FEI 3012216737

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 6, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lake Forest, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)